Dairy and nondairy proteins as nano‐architecture structures for delivering phenolic compounds: Unraveling their molecular interactions to maximize health benefits
Authors:
- Cristine Couto de AlmeidaCACristine Couto de Almeida
- Diego dos Santos BaiãoDiego dos Santos Baião
- Davi Vieira Teixeira da SilvaDSDavi Vieira Teixeira da Silva
- Lucileno Rodrigues da TrindadeLTLucileno Rodrigues da Trindade
- Patricia Ribeiro PereiraPatricia Ribeiro Pereira
- Carlos Adam Conte‐JuniorCarlos Adam Conte‐Junior
- Vania Margaret Flosi PaschoalinVania Margaret Flosi Paschoalin
Open Access
- 12 November 2024
- journal article
- review article
- Published by Wiley in Comprehensive Reviews in Food Science and Food Safety
- Vol. 23 (6) , e70053
Abstract
Phenolic compounds are recognized for their benefits against degenerative diseases. Clinical and nutritional applications are limited by their low solubility, stability, and bioavailability, compromising their efficacy. Natural macromolecules, such as lipids, polysaccharides, and proteins, employed as delivery systems can efficiently overcome these limitations. In this sense, proteins are attractive due to their biocompatibility and dynamic structure properties, functional adaptability and self‐assembly capabilities, offering stability, efficient encapsulation, and controlled release. This review explores the potential use of dairy proteins, caseins, and whey proteins, and, alternatively, nondairy proteins, gelatin, human serum albumin, maize zein, and soybean proteins, in building wall materials for the delivery of phenolic compounds. To optimize performance, aspects, such as protein–phenolic affinity and complex stability/activity, should be considered when designing particle nano‐architecture. Molecular interactions between protein–phenolic compound complexes are, thus, further discussed, as well as the effects of temperature and pH and strategies to stabilize and preserve nano‐architecture and retain phenolic compound activity. All proteins harbor one or more putative binding sites, shared or not, depending on the phenolic compound. Preservation techniques are still a case‐to‐case study, as no behavior patterns among different complexes are noted. Safety aspects necessary for the marketing of nanoproducts, such as characterization, toxicity assessments, and post‐market monitoring as defined by the European Food Safety Authority and the Food and Drug Administration, are discussed, evidencing the need for a unified regulation. This review broadens our understanding and opens new opportunities for the development of novel protein‐based nanocarriers to obtain more effective and stable products, enhancing phenolic compound delivery and health benefits.Keywords
Funding Information
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 201 references indexed in Scilit:
- Self‐Assembled Nanocarrier Delivery Systems for Bioactive CompoundsSmall, 2024
- Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation modelsMedcomm, 2023
- Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospectsPhytotherapy Research, 2023
- Biopolymers for Drug Delivery2020
- Milk Proteins2015
- Nano‐ and Microencapsulation of Phytochemicals2014
- Milk Proteins: General and Historical Aspects2003
- Comparison of the structural and dynamical properties of holo and apo bovine α-lactalbumin by NMR spectroscopyJournal of Molecular Biology, 2001
- Soybeans1997
- Some Physical Properties of RutinJournal of the American Pharmaceutical Association (Scientific ed.), 1952